1. Home
  2. QTTB vs SCNX Comparison

QTTB vs SCNX Comparison

Compare QTTB & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$3.05

Market Cap

25.1M

Sector

Health Care

ML Signal

HOLD

Logo Scienture Holdings Inc.

SCNX

Scienture Holdings Inc.

HOLD

Current Price

$0.55

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTTB
SCNX
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.1M
24.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
QTTB
SCNX
Price
$3.05
$0.55
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$7.33
N/A
AVG Volume (30 Days)
9.0M
1.8M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$653,391.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
207.88
52 Week Low
$1.35
$0.46
52 Week High
$6.37
$8.19

Technical Indicators

Market Signals
Indicator
QTTB
SCNX
Relative Strength Index (RSI) 53.39 42.10
Support Level $3.06 $0.60
Resistance Level $3.96 $0.75
Average True Range (ATR) 0.53 0.05
MACD 0.01 0.01
Stochastic Oscillator 24.37 8.45

Price Performance

Historical Comparison
QTTB
SCNX

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

About SCNX Scienture Holdings Inc.

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Share on Social Networks: